Citius Pharmaceuticals, Inc. — Director's Dealing 2018

Sep 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2018-09-04

Reporting Person: Webb Carol (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-04	Options to Purchase Common Stock	$1.62	A	15000	Acquired	2028-09-04	Common Stock (15000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$3.45	2027-09-13	Common Stock (10000)	10000	Direct
Options to Purchase Common Stock	$0.015	2024-03-17	Common Stock (12071)	12071	Direct
Options to Purchase Common Stock	$12.00	2026-06-23	Common Stock (13334)	13334	Direct

Footnotes

F1: The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.

F2: The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018.

F3: The option vested in 1/3 increments over a three year period with the first installment vesting on March 17, 2015.

F4: The options vested in full on the first anniversary of the date of grant.